Abiomed, Inc. (ABMD) Tops Q2 EPS by 15c
Abiomed, Inc. (NASDAQ: ABMD) reported Q2 EPS of $0.20, $0.15 better than the analyst estimate of $0.05. Revenue for the quarter came in at $37.4 million versus the consensus estimate of $37.47 million.
For earnings history and earnings-related data on Abiomed, Inc. (ABMD) click here.
For earnings history and earnings-related data on Abiomed, Inc. (ABMD) click here.